Abstract
The coronavirus disease that initiates in 2019 (COVID-19) has proven to be highly contagious since it became pandemic quickly and nowadays presents higher transmission rates worldwide, including small Brazilian cities, as Ijuí. Located in the northwestern of the State of Rio Grande do Sul (RS) with 83,475 inhabitants, Ijuí was selected to receive a population-based survey divided into four steps separated by 15 days each that involved 1,750 subjects. Subjects were tested for the presence of antibodies against coronavirus (SARS CoV-2) and answered questions about social distance adherence, daily routine, comorbidities, and sociodemographic characteristics. In parallel, the local government registered the official COVID-19 cases in Ijuí. In this study, we demonstrated the levels of social distancing adherence and the beginning of COVID-19 community transmission in Ijuí and showed some predictions for cases, hospitalization, and deaths. We concluded that the insufficient social distancing registered in the population-based study might be related to the rapid increase of COVID-19 cases in Ijuí. Our study predicts a closer outbreak of community infection of COVID-19, which could be avoided or attenuated if the levels of the social distancing in the population increase in the next weeks.
Competing Interest Statement
The authors declare no competing interests regarding financial, academic, professional, or commercial issues. However, since all authors live in Ijuí, we declare a conflict of interest about a preoccupation about a COVID-19 outbreak in our city.
Funding Statement
Coordination and Improvement of Higher Level or Education Personnel (Capes), Rio Grande do Sul State government, Federal University of Pelotas, and Regional University of Northwestern Rio Grande do Sul State (UNIJUI) supported this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Brazilian National Ethics Committee (process number 30415520.2.0000.5313), with written informed consent from all participants.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The COVID-19 data that support the findings of this study are available in government repository, which is daily updated on the government website and predictions were made accordingly the math-epidemiological web sites. All data of this study are available from the corresponding author upon reasonable request.
https://www.ijui.rs.gov.br/noticias/municipio_disponibiliza_painel_de_informacoes_sobre_casos
https://datastudio.google.com/reporting/4ff82b8a-a9ff-4577-b239-da2e38d24443/page/vBjQB